Our study has some limitations due to the lack of a comprehensive assessment of bone mineral changes in children with CKD, which requires invasive blood sampling and the determination of a wide range of parameters in serum: P content, albumin-adjusted total Ca, ionized Ca2+, parathormone, and bone fraction of alkaline phosphatase. The gene discussed is ALB; the disease is chronic kidney disease.